Submit manuscript at http://omicsonline.org/submitmanuscript-pulmonary-respiratory-medicine-open-access.php or send as an e-mail attachment to the Editorial Office at email@example.com
Impact Factor: 1.01*
Journal of Pulmonary & Respiratory Medicine is a peer reviewed medical journal that focus on a wide range of areas in this field including diseases related to respiratory system and treatment methods and creates a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.
Pulmonary & Respiratory Medicine Journal is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in the field and provide online access to the researchers worldwide without any restrictions or subscriptions.
This scientific journal brings out the scientific works in the field of pulmonology, respiratory medicine, thoracic surgery, lung diseases (chronic obstructive pulmonary disease, acute lung injury, acute respiratory distress syndrome, tuberculosis, pulmonary hypertension, pulmonary embolism, pulmonary edema), pulmonary function tests, respiratory care and respiratory therapy to people in electronic forms are immediately freely available to read download and share to improve the Open Access motto.
This respiratory journal is using Editorial Manager System for online manuscript submission, review and tracking. Editorial board members of the Pulmonary & Respiratory Medicine or outside experts review manuscripts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript.
Please visit why publish with Pulmonary & Respiratory Medicine for publishing/author benefits.
Bronchoscopy is the endoscopic technique of visualizing airways carrying air from trachea or windpipe to the lungs for diagnostic and therapeutic purposes. Bronchoscope is a thin flexible tube to be inserted into airways through nose or mouth or through tracheostomy. Bronchoscopy is of two types, rigid and flexible.
Chronic obstructive pulmonary disease (COPD) is a most common progressive lung disease that makes it hard to breathe. Two main forms of COPD are chronic bronchitis and emphysema. Treatment include inhaled bronchodilators, steroids, quitting smoking, vaccinations and rehabilitation. Long term oxygen therapy or lung transplantation benefit some people.
Lung nodules or coin lesion are smaller infiltrates or white masses of tissue in the lung distinguished from larger lung tumors. Lung nodules are oval or round in shape and ranges 3 centimetres in diameter. If the growth exceeds it is known as pulmonary mass.
Pulmonary alveolar proteinosis ( PAP) characterized by abnormal alveolar filling with surfactants, floccular material and interferes with gas exchange is a rare lung disease. Two forms are primary and secondary caused by lung infections, hematologic malignancies, inhalation of mineral dusts, silica, titanium oxide, aluminium and insecticides.
Pulmonary angiography is cardiological imaging test using special dye and x-rays to detect arteriovenous malformations and how blood flows through lungs. Direct angiography involves injection of dye into right heart with subsequent fluoroscopy into the circulation, to see shape, size and pulmonary vessels of lungs.
Aspergillosis is an infection caused by fungus Aspergilus. Pulmonary aspergillosis is a long term aspergillus infection of the lung. Patients with CPA have or have had lung diseases (tuberculosis, lung cancer, COPD, mycobacterial infection, emphysema, asthma and silicosis).
Pulmonary cancer or lung cancer is also termed as carcinoma of the lung or pulmonary carcinoma is uncontrollable cell growth in tissues of the lung. Carcinogenic factors( chemicals, cigarette smoking, air pollution and asbestos attribute lung cancer). Treatment involves surgery, chemotherapy and radiation therapy.
Pulmonary circulation forms a closed circuit between the heart and the lungs and is the movement of blood from the heart, to the lungs, and back to the heart again. It begins with the right ventricle which pumps deoxygenated blood away from the heart to the pulmonary artery for oxygenation.
Pulmonary thromboembolism is a blockage of the pulmonary arteries caused by the blood clot ( thrombus) that travels from the legs or rarely other parts of the body to the lungs, it originate in the deep venous system.
Pulmonary critical care is caring for patients with diseases related to lungs such as asthma, lung cancer, tuberculosis, fungal infections to the lung, pulmonary vascular diseases and breathing etc. Critical care provides clinical evaluation, diagnosis and treatment services to patients with health problems.
Bronchopulmonary dysplasia occurs in premature babies and who have respiratory problems after birth is a chronic lung disorder. Pulmonary dysplasia can lead to inflammation and scarring in the lungs. BPD is classifierd into mild, moderate and severe.
Pulmonary oedema also called edema is the accumulation of fluids in the lungs airspaces and parenchyma. It occurs due to failure of left ventricle of the heart or an injury to the lung parenchyma termed as cardiogenic and noncardiogenic pulmonary edema respectively.
Pulmonary effusion or pleural effusion is the accumulation of excess fluid around the lung in the pleural cavity.Treatment varies with the underlying cause of the pleural effusion and may be directed at removing the fluid, preventing its re-accumulation.
Pulmonary eosinophilia is the inflammation of lungs from an increased eosinophilic cells . Symptoms are chest pain, dry cough, fever, general ill feeling, rashes, shortness of breath, wheezing and rapid respiratory rate. Pulmonary eosinophila is a heterogeneous group of disorders.
Pulmonary fibrosis ( idiopathic) causes thick, stiff scar tissue to grow inside the lungs. The scar tissue slows oxygen flow from the lungs to blood and make hard to breathe. Symptoms include shortness of breath, dry cough, fatigue, unexplained weightloss, aches in muscles and joints.
Pulmonary function tests are group of non invasive diagnostic tests that evaluates respiratory system and provide measures of lungs take in and release air and gases (oxygen) from atmosphere into body’s circulation. Measurements are done by spirometry, lung volumes, diffusing capacity.
Pulmonary hypoplasia is the spectrum of malformations causing incomplete development of the lungs, often occurs secondary to other fetal abnormalities. It results in less in size or number of alveoli or broncho pulmonary segments.
Interstitial pulmonary fibrosis is the inflammation of walls of respiratory airspaces of the lungs that proceeds to scarring in the lungs. The inflammation may be granulomatous or nongranulomatous. The treatment for IPH cannot remove scarring that already occurred.
Pulmonary lymphoma is the malignancy arising from lymphocytes or lymphoblasts of lung parenchyma. Primary pulmonary lymphoma is rare non Hodgkin lymphoma usually secondary pulmonary lymphoma includes Hodgkin disease and non Hodgkin lymphoma . Diagnosis and determining treatment is often difficult in lymphomatous involvement of the lungs.
Pulmonary neoplasm refers to tumor, an abnormal growth in the lung. Neoplastic growths may be benign or malignant cellular production. Treatment is dependant on the location and stage of the growth. Biopsy will confirm the malignancy and imaging tests are used to detect the condition.
Clinical management and health maintenance integrates pulmonary rehabilitation of those patients with chronic respiratory disease who continue to have decreased function or remain symptomatic despite standard medical treatment. It refers to services that are administered to patients of respiratory disease
Pulmonary vasculitis encompass a number of distinct disorders affecting the pulmonary arteries, veins and capillaries. It is a heterogeneous group of diseases that are pathologically characterised by destruction of blood vessel. Diagnosis includes chest radiography and CT in patients with clinically suspected with pulmonary vasculitis.
Pulmonology or chest medicine and respiratory medicine is the branch of internal medicine concerned with diseases of lungs, respiratory tract, bronchial tubes, upper respiratory tract and heart as well. Treatment includes oxygen therapy, medication of most diseases either by inhaling bronchodilators, steroids and in oral form.
Pulmonary arterial hypertension is high blood pressure in the arteries of lungs carrying blood from heart to the lungs from where oxygen is delivered throughout the body. Pulmonary arterial hypertension constricts pulmonary arteries, tends heart to work faster increasing BP within the lungs.
Pulmonary parenchyma refers to the portion of lung often used solely to alveolar tissue and any form of lung tissue including bronchioles, bronchi, bloodvessels, interstitium and alveoli involved in gas transfer. CT is used in assessing overall decreases radiographic density with its superior contrast resolution.
Journal of Pulmonary & Respiratory Medicine is associated with "International Conference and Exhibition on Lung Disorders & Therapeutics", which is to be held on July 13-15, 2015 at DoubleTree by Hilton, Baltimore, USA. The conference will be organized around the theme “Optimizing research strategies for breakthrough innovations in Lung disorders treatment”.
OMICS International organizes 300+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 400+ scholarly open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
*Unofficial 2014 Impact Factor was established by dividing the number of articles published in 2012 and 2013 with the number of times they are cited in 2014 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2012 and 2013, and ‘Y’ is the number of times these articles were cited in indexed journals during 2014 than, impact factor = X/Y